WD-34
Malaria prophylaxis (also babesiosis, toxoplasmosis)
PreclinicalActive
Key Facts
Indication
Malaria prophylaxis (also babesiosis, toxoplasmosis)
Phase
Preclinical
Status
Active
Company
About AdAlta
Australian biotech delivering CAR‑T and i‑body therapies for solid tumours, fibrosis and malaria.
View full company profile